Intervention targeting the phosphorylation of JAK2 and STAT3 may inhibit the JAK2/STAT3/HMGCS2 signaling pathway, thereby alleviating hyperuricemia-induced mitochondrial dysfunction, oxidative stress, and energy metabolism disorders, and potentially improving heart dysfunction. This evidence concerns the gene JAK2 and Disorder of energy metabolism.